NanoVibronix Statistics
Total Valuation
NanoVibronix has a market cap or net worth of $4.79 million. The enterprise value is $2.99 million.
Important Dates
The next estimated earnings date is Friday, November 14, 2025.
| Earnings Date | Nov 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
NanoVibronix has 1.01 million shares outstanding. The number of shares has increased by 630.56% in one year.
| Current Share Class | 1.01M |
| Shares Outstanding | 1.01M |
| Shares Change (YoY) | +630.56% |
| Shares Change (QoQ) | +673.88% |
| Owned by Insiders (%) | 0.00% |
| Owned by Institutions (%) | 1.53% |
| Float | 1.01M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.31 |
| Forward PS | n/a |
| PB Ratio | 0.09 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.28 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.05, with a Debt / Equity ratio of 0.05.
| Current Ratio | 1.05 |
| Quick Ratio | 0.63 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -22.87 |
Financial Efficiency
Return on equity (ROE) is -38.19% and return on invested capital (ROIC) is -21.14%.
| Return on Equity (ROE) | -38.19% |
| Return on Assets (ROA) | -16.85% |
| Return on Invested Capital (ROIC) | -21.14% |
| Return on Capital Employed (ROCE) | -17.15% |
| Revenue Per Employee | $75,452 |
| Profits Per Employee | -$154,871 |
| Employee Count | 31 |
| Asset Turnover | 0.08 |
| Inventory Turnover | 0.69 |
Taxes
In the past 12 months, NanoVibronix has paid $85,000 in taxes.
| Income Tax | 85,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -92.27% in the last 52 weeks. The beta is 2.05, so NanoVibronix's price volatility has been higher than the market average.
| Beta (5Y) | 2.05 |
| 52-Week Price Change | -92.27% |
| 50-Day Moving Average | 6.11 |
| 200-Day Moving Average | 22.55 |
| Relative Strength Index (RSI) | 35.53 |
| Average Volume (20 Days) | 60,123 |
Short Selling Information
The latest short interest is 91,125, so 9.01% of the outstanding shares have been sold short.
| Short Interest | 91,125 |
| Short Previous Month | 47,646 |
| Short % of Shares Out | 9.01% |
| Short % of Float | 9.01% |
| Short Ratio (days to cover) | 0.03 |
Income Statement
In the last 12 months, NanoVibronix had revenue of $2.34 million and -$4.80 million in losses. Loss per share was -$32.19.
| Revenue | 2.34M |
| Gross Profit | 750,000 |
| Operating Income | -7.71M |
| Pretax Income | -8.19M |
| Net Income | -4.80M |
| EBITDA | -7.33M |
| EBIT | -7.71M |
| Loss Per Share | -$32.19 |
Full Income StatementBalance Sheet
The company has $4.03 million in cash and $2.13 million in debt, giving a net cash position of $1.91 million or $1.88 per share.
| Cash & Cash Equivalents | 4.03M |
| Total Debt | 2.13M |
| Net Cash | 1.91M |
| Net Cash Per Share | $1.88 |
| Equity (Book Value) | 40.48M |
| Book Value Per Share | 51.41 |
| Working Capital | 349,000 |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$6.11 million and capital expenditures -$9,000, giving a free cash flow of -$6.12 million.
| Operating Cash Flow | -6.11M |
| Capital Expenditures | -9,000 |
| Free Cash Flow | -6.12M |
| FCF Per Share | -$6.05 |
Full Cash Flow StatementMargins
| Gross Margin | 32.06% |
| Operating Margin | -329.50% |
| Pretax Margin | -350.02% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
NanoVibronix does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -630.56% |
| Shareholder Yield | -630.56% |
| Earnings Yield | -98.11% |
| FCF Yield | -125.04% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on August 12, 2025. It was a reverse split with a ratio of 1:10.
| Last Split Date | Aug 12, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
NanoVibronix has an Altman Z-Score of -2.38. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.38 |
| Piotroski F-Score | n/a |
